BioNTech SE (BNTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for BioNTech SE, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -17.95x | -39.76x | 24.69x | 3.62x | 5.37x | 1033.15x |
| P/B Ratio | 1.02x | 1.36x | 1.13x | 1.70x | 4.65x | 11.45x |
| P/S Ratio | 7.10x | 9.62x | 6.02x | 1.97x | 2.91x | 32.56x |
| Profitability | ||||||
| Gross Margin | 77.6% | 80.3% | 84.3% | 82.7% | 84.7% | 87.7% |
| Operating Margin | -22.6% | -47.8% | 18.1% | 73.0% | 80.5% | -17.1% |
| Net Margin | -39.6% | -24.2% | 24.4% | 54.5% | 54.2% | 3.2% |
| EBITDA Margin | -9.3% | -13.3% | 36.1% | 75.7% | 79.1% | -21.8% |
| Liquidity | ||||||
| Current Ratio | 7.54x | 7.45x | 9.43x | 7.43x | 4.33x | 2.75x |
| Quick Ratio | 7.49x | 7.34x | 9.26x | 7.28x | 4.18x | 2.64x |
| Leverage | ||||||
| Debt/Equity | 0.01x | 0.01x | 0.01x | 0.01x | 0.03x | 0.18x |
YoY = year-over-year change. Source: FMP..